Corey Nislow

Corey Nislow is a Professor at the University of British Columbia's Faculty of Pharmaceutical Sciences. His research spans genomics, biotechnology, and drug discovery, with a focus on chemical genomics and space biology. He leads a lab developing molecularly barcoded mutant collections for gene-drug interaction studies in yeast, bacterial pathogens, and human fungal pathogens, utilizing high-throughput screening platforms and next-generation sequencing technologies.

• PhD in Cell and Molecular Biology, University of Colorado
• BA in Developmental Biology, New College
• American Cancer Society Postdoctoral Fellow

The lab's work centers on understanding genotype-phenotype relationships through chemical genomics and genome architecture studies. They have developed innovative tools like nucleosome-seq and pathway-specific sequencing assays, while directing UBC's sequencing center. Research explores environmental/drug stress effects on gene function, chromatin influence on gene expression, and genomic applications in human biology.

Recent publications emphasize chemical-genetic interactions in yeast, space biology experiments, and microbiome research. His work includes microbiome responses to environmental stressors, cancer metabolism, and genomic screening methodologies. Publications trend toward translational applications of genomics in medicine and biotechnology.

Scientific Achievements:

• American Cancer Society Postdoctoral Fellow
• Director, Donnelly Sequencing Centre (previous role)
• Co-developer of molecular barcoding technologies

Dr. Nislow teaches biotechnology, genomics, and drug discovery courses, with past experience in critical thinking instruction. He collaborates extensively within UBC and beyond, particularly with Dr. Guri Giaever. Current projects investigate gene variants' impact on therapeutic responses and the intersection of chemical biology with genomics.